Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice

Journal of Physiology

Volumn 587, Issue 8, 2009, Pages 1755-1767

  Olfert, Mark I ^a   Howlett, Richard A ^a   Tang, Kechun ^a   Dalton, Nancy D ^a   Gu, Yusu ^a   Peterson, Kirk L ^a   Wagner, Peter D ^a   Breen, Ellen C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; CREATINE KINASE; DOBUTAMINE; VASCULOTROPIN; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; 6 PHOSPHOFRUCTOKINASE; CRE RECOMBINASE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CROSS BREEDING; ENDURANCE; EXERCISE TOLERANCE; GASTROCNEMIUS MUSCLE; HEART FUNCTION; HEART MUSCLE; HINDLIMB; MANOMETRY; MOUSE; MUSCLE CAPILLARY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RUNNING; SKELETAL MUSCLE; TRANSGENIC MOUSE; TRANSTHORACIC ECHOCARDIOGRAPHY; ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; ENDURANCE TRAINING; HEART MUSCLE CAPILLARY; HEART MUSCLE DP-DT;

ANIMALS; CAPILLARIES; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; GENOTYPE; HEMATOCRIT; HEMOGLOBINS; HISTOCYTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOCARDIUM; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 65249181467     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.164384     Document Type: Article

References (46)

1. Baffert F, Thurston G, Rochon-Duck M, Le T, Brekken R & McDonald DM (2004). Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res 94, 984-992.
2. Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW & Peterson KL (2004). The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failure. Proc Natl Acad Sci U S A 101, 3697-3702.
3. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C & Gea J (2008). Cytokine profile in quadriceps muscles of patients with severe chronic obstructive pulmonary disease. Thorax 63, 100-107.
4. Benjamin LE, Golijanin D, Itin A, Pode D & Keshet E (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103, 159-165.
5. Bergmeyer HU (1974). Methods in Enzymatic Analysis. Academic Press, New York.
6. Breen EC, Johnson EC, Wagner H, Tseng H-M, Sung LA & Wagner PD (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81, 355-361.
7. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ & Kahn CR (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559-569.
8. Bylund AC, Hammarsten J, Holm J & Schersten T (1976). Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. Eur J Clin Invest 6, 425-429.
9. Carmeliet P, Ferreira V, Breier G, Pollefeety S, Kieckens L, Geertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Riasu W & Nagy A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
10. Drorbaugh JE & Fenn WO (1955). A barometric method for measuring ventilation in newborn infants. Pediatrics 16, 81-87.
11. Ferrara N (1999). Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56, 794-814.
12. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ & Moore MW (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
13. Ferrara N, Gerber H-P & LeCouter J (2003). The biology of VEGF and its receptors. Nat Med 9, 669-676.
14. Folkman J (1976). The vascularization of tumors. Sci Am 234, 58-73.
15. Garry DJ, Ordway GA, Lorenz JN, Radford NB, Chin ER, Grange RW, Bassel-Duby R & Williams RS (1998). Mice without myoglobin. Nature 395, 905-908.
16. 2. Am J Physiol Heart Circ Physiol 251, H789-H799.
17. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J & Broquetas J (2001). Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17, 939-945.
18. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M & Ferrara N (1999). VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159.
19. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath AK, Huang Y, Hickey R, Dalton N, Peterson KL, Ross J Jr, Chien KR & Ferrara N (2001). A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98, 5780-5785.
20. Gödecke A, Flögel U, Zanger K, Ding Z, Hirchenhain J, Decking UK & Schrader J (1999). Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc Natl Acad Sci U S A 96, 10495-10500.
21. 2 gradients in heavily working red muscle. Am J Physiol Heart Circ Physiol 259, H84-92.
22. Gustafsson T, Puntschart A, Kaijser L, Jansson E & Sundberg CJ (1999). Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 276, H679-685.
23. 2 diffusing capacity: evidence from muscle function in situ. J Appl Physiol 88, 560-566.
24. Holloszy J (1976). Adaptations of muscular tissue to training. Prog Cardiovasc Dis 18, 445-458.
25. Holloszy JO & Coyle EF (1984). Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56, 831-838.
26. Howlett RA, Gonzalez NC, Wagner HE, Fu Z, Britton SL, Koch LG & Wagner PD (2003). Genetic models in applied physiology: Skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance. J Appl Physiol 94, 1682-1688.
27. Jacky JP (1978). A plethysmograph for long-term measurements of ventilation in unrestrained animals. J Appl Physiol 45, 644-647.
28. Jansson E, Johansson J, Sylven C & Kaijser L (1988). Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol 8, 17-29.
29. Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O'Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ & McDonald DM (2006). VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290, H560-576.
30. Kivela R, Silvennoinen M, Lehti M, Jalava S, Vihko V & Kainulainen H (2008). Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc Diabetol 7, 13.
31. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP & Iruela-Arispe ML (2007). Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703.
32. Lowry CV, Kimmey JS, Felder S, Chi MM, Kaiser KK, Passonneau PN, Kirk KA & Lowry OH (1978). Enzyme patterns in single human muscle fibers. J Biol Chem 253, 8269-8277.
33. Lundgren F, Dahllof AG, Schersten T & Bylund-Fellenius AC (1989). Muscle enzyme adaptation in patients with peripheral arterial insufficiency: Spontaneous adaptation, effect of different treatments and consequences on walking performance. Clin Sci (Lond) 77, 485-493.
34. Meeson AP, Radford N, Shelton JM, Mammen PP, DiMaio JM, Hutcheson K, Kong Y, Elterman J, Williams RS & Garry DJ (2001). Adaptive mechanisms that preserve cardiac function in mice without myoglobin. Circ Res 88, 713-720.
35. Mrazkova O, Grim M & Carlson BM (1986). Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am J Anat 177, 141-148.
36. Ogilvie RW & Feeback DL (1990). A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC. Stain Technol 65, 231-241.
37. Olfert IM, Breen EC, Mathieu-Costello O & Wagner PD (2001). Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J Appl Physiol 91, 1176-1184.
38. Prior BM, Lloyd PG, Yang HT & Terjung RL (2003). Exercise-induced vascular remodeling. Exerc Sport Sci Rev 31, 26-33.
39. Prior BM, Yang HT & Terjung RL (2004). What makes vessels grow with exercise training? J Appl Physiol 97, 1119-1128.
40. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA & Wagner PD (1999). Human VEGF gene expression in skeletal muscle: Effect of acute normoxic and hypoxic exercise. Am J Physiol Heart Circ Physiol 277, H2247-2252.
41. Robinson CJ & Stringer SE (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114, 853-865.
42. Sanchez J, Brunet A, Medrano G, Debesse B & Derenne JP (1988). Metabolic enzymatic activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease. Eur Respir J 1, 376-383.
43. Srere PA (1969). Citrate synthase. Methods Enzymol 13, 3-5.
44. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR & Ross J (1996). Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94, 1109-1117.
45. Tang K, Breen EC, Gerber HP, Ferrara NM & Wagner PD (2004). Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18, 63-69.
46. Trask RV & Billadello JJ (1990). Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim Biophys Acta 1049, 182-188.